• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥氮平引起的体重增加以及脂质和葡萄糖代谢紊乱。

Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.

作者信息

eder-Ischia Ursula, Ebenbichler Christoph, Fleischhacker W Wolfgang

机构信息

Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria.

出版信息

Essent Psychopharmacol. 2005;6(2):112-7.

PMID:15765795
Abstract

Among the atypical antipsychotics, clozapine and olanzapine are known to cause significant weight gain. Along with quetiapine, they may impair glucose metabolism and increase the risk for type 2 diabetes. They are also associated with a rise in triglyceride levels and an increased risk for coronary artery disease. Clinicians should take these risks seriously in prescribing these antipsychotics and employ intelligent safeguards if and when they use them.

摘要

在非典型抗精神病药物中,已知氯氮平和奥氮平会导致显著体重增加。与喹硫平一起,它们可能损害葡萄糖代谢并增加2型糖尿病风险。它们还与甘油三酯水平升高及冠状动脉疾病风险增加有关。临床医生在开具这些抗精神病药物处方时应认真对待这些风险,并且在使用时应采取明智的预防措施。

相似文献

1
Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.奥氮平引起的体重增加以及脂质和葡萄糖代谢紊乱。
Essent Psychopharmacol. 2005;6(2):112-7.
2
The implications of weight changes with antipsychotic treatment.抗精神病药物治疗引起体重变化的影响。
J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S21-6. doi: 10.1097/01.jcp.0000084037.22282.a3.
3
Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.雌性大鼠长期服用氯氮平不会导致体重增加或代谢异常,但会增加肥胖:对抗精神病药物所致体重增加动物模型的启示。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):428-36. doi: 10.1016/j.pnpbp.2007.09.012. Epub 2007 Sep 22.
4
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.抗精神病药物的代谢效应:体重增加、糖尿病和脂质异常。
Can J Psychiatry. 2001 Apr;46(3):273-81. doi: 10.1177/070674370104600308.
5
[The appearance of metabolic syndrome in treatment with atypical antipsychotics].[非典型抗精神病药物治疗中代谢综合征的出现]
Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(11):62-9.
6
Profound hypertriglyceridemia and weight gain in the first week following initiation of olanzapine: a case report with implications for lipid monitoring guidelines.
Psychosomatics. 2013 Jul-Aug;54(4):392-4. doi: 10.1016/j.psym.2012.10.005. Epub 2012 Dec 20.
7
Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia.
Intern Med. 2008;47(3):181-2. doi: 10.2169/internalmedicine.47.0557. Epub 2008 Feb 1.
8
Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.奥氮平直接作用而非体重增加导致的高甘油三酯血症:一例报告
J Clin Psychiatry. 2006 Sep;67(9):1473-4. doi: 10.4088/jcp.v67n0922e.
9
Hyperglycemia and antipsychotic medications.高血糖与抗精神病药物
J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1.
10
The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.非典型抗精神病药物奥氮平通过作用于5-羟色胺受体2C导致体重增加。
J Clin Invest. 2017 Sep 1;127(9):3402-3406. doi: 10.1172/JCI93362. Epub 2017 Aug 14.

引用本文的文献

1
RNA sequencing reveals a slow to fast muscle fiber type transition after olanzapine infusion in rats.RNA测序揭示了大鼠注射奥氮平后慢肌纤维向快肌纤维类型的转变。
PLoS One. 2015 Apr 20;10(4):e0123966. doi: 10.1371/journal.pone.0123966. eCollection 2015.
2
The effect of ranitidine on olanzapine-induced weight gain.雷尼替丁对奥氮平引起的体重增加的影响。
Biomed Res Int. 2013;2013:639391. doi: 10.1155/2013/639391. Epub 2013 Jul 30.
3
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients.精神分裂症患者血浆中载脂蛋白A-I水平降低。
J Neural Transm (Vienna). 2007;114(5):657-63. doi: 10.1007/s00702-006-0607-2. Epub 2006 Dec 14.